EP3695012
INHIBITION OF HSD17B13 IN THE TREATMENT OF LIVER DISEASE IN PATIENTS EXPRESSING THE PNPLA3 I148M VARIATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.10.2018EP published:
8.3.2023EP application number:
18803806.1
EPO information:
European Patent Register
Max expiry date:
10.10.2038
Title in English:
INHIBITION OF HSD17B13 IN THE TREATMENT OF LIVER DISEASE IN PATIENTS EXPRESSING THE PNPLA3 I148M VARIATIONLanguage of the patent:
English
Timeline
Today
11.10.2018EP application
8.3.2023EP Publication
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
XIN, YurongAddress:
Tarrytown New York 10591, US
Name:
GROMADA, JesperAddress:
Tarrytown New York 10591, US
Name:
CHENG, XipingAddress:
Tarrytown New York 10591, US
Name:
DEWEY, FrederickAddress:
Tarrytown New York 10591, US
Name:
TESLOVICH DOSTAL, TanyaAddress:
Tarrytown New York 10591, US
Name:
SCHURMANN, ClaudiaAddress:
Tarrytown New York 10591, US
Name:
BARAS, ArisAddress:
Bedford Corners, New York 10549, US
Name:
ABUL-HUSN, NouraAddress:
New York, NY 10128, US
Priority
Number:
201762570985 PDate:
11.10.2017Country:
US
Classification
Categories:
C12Q 1/6883